BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 7913004)

  • 1. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study.
    Porkka KV; Taimela S; Kontula K; Lehtimäki T; Aalto-Setälä K; Akerblom HK; Viikari JS
    Clin Genet; 1994 Mar; 45(3):113-21. PubMed ID: 7913004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones.
    Kessling A; Ouellette S; Bouffard O; Chamberland A; Bétard C; Selinger E; Xhignesse M; Lussier-Cacan S; Davignon J
    Am J Hum Genet; 1992 Jan; 50(1):92-106. PubMed ID: 1346081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children.
    Xu CF; Nanjee MN; Savill J; Talmud PJ; Angelico F; Del Ben M; Antonini R; Mazzarella B; Miller N; Humphries SE
    Am J Hum Genet; 1990 Sep; 47(3):429-39. PubMed ID: 1975478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5' flanking region of the insulin gene as possible markers of coronary heart disease.
    Wick U; Witt E; Engel W
    Clin Genet; 1995 Apr; 47(4):184-90. PubMed ID: 7628120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.
    Gajra B; Candlish JK; Saha N; Heng CK; Soemantri AG; Tay JS
    Genet Epidemiol; 1994; 11(1):19-27. PubMed ID: 8013886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Within-individual variation in serum cholesterol levels: association with DNA polymorphisms at the apolipoprotein B and AI-CIII-AIV loci in patients with peripheral arterial disease.
    Monsalve MV; Robinson D; Woolcock NE; Powell JT; Greenhalgh RM; Humphries SE
    Clin Genet; 1991 Apr; 39(4):260-73. PubMed ID: 1676938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymorphisms of the apolipoprotein B and A-I/C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood.
    Aalto-Setälä K; Viikari J; Akerblom HK; Kuusela V; Kontula K
    J Lipid Res; 1991 Sep; 32(9):1477-87. PubMed ID: 1684378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls.
    Xu CF; Angelico F; Del Ben M; Humphries S
    Genet Epidemiol; 1993; 10(2):113-22. PubMed ID: 8339925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary intake and gene variation influence the response of plasma lipids to dietary intervention.
    Talmud PJ; Boerwinkle E; Xu CF; Tikkanen MJ; Pietinen P; Huttunen JK; Humphries S
    Genet Epidemiol; 1992; 9(4):249-60. PubMed ID: 1356882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia.
    Buzza M; Fripp Y; Mitchell RJ
    Ann Hum Biol; 2001; 28(5):481-90. PubMed ID: 11572515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland.
    Aalto-Setälä K; Tikkanen MJ; Taskinen MR; Nieminen M; Holmberg P; Kontula K
    Atherosclerosis; 1988 Nov; 74(1-2):47-54. PubMed ID: 2905601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk.
    Sheehan D; Bennett T; Cashman K
    Ir J Med Sci; 2000; 169(1):50-4. PubMed ID: 10846860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Wattigney WA; Berenson GS
    Atherosclerosis; 1996 Nov; 127(1):73-9. PubMed ID: 9006807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Ordovas JM; Civeira F; Genest J; Craig S; Robbins AH; Meade T; Pocovi M; Frossard PM; Masharani U; Wilson PW
    Atherosclerosis; 1991 Mar; 87(1):75-86. PubMed ID: 1678604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of DNA polymorphisms of the apolipoprotein genes to study the role of genetic variation in the determination of serum lipid levels.
    Humphries SE; Talmud PJ; Kessling AM
    Ciba Found Symp; 1987; 130():128-49. PubMed ID: 2894927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.